{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:22:12Z","timestamp":1785237732865,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002888","name":"Beijing Municipal Commission of Education","doi-asserted-by":"publisher","award":["KZ201910025033"],"award-info":[{"award-number":["KZ201910025033"]}],"id":[{"id":"10.13039\/501100002888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"publisher","award":["ZYLX201814"],"award-info":[{"award-number":["ZYLX201814"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.wneu.2021.11.103","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T10:20:50Z","timestamp":1638181250000},"page":"e23-e31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinicopathologic Features and Prognosis of Olfactory Neuroblastoma with Isocitrate Dehydrogenase 2 Mutations"],"prefix":"10.1016","volume":"159","author":[{"given":"Linlin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianduo","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2021.11.103_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13014-019-1313-1","article-title":"Management of orbital invasion in esthesioneuroblastoma: 14 years' experience","volume":"14","author":"Li","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.wneu.2021.11.103_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.celrep.2018.09.047","article-title":"Integrated multi-omic analysis of esthesioneuroblastomas identifies two subgroups linked to cell ontogeny","volume":"25","author":"Classe","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.wneu.2021.11.103_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00401-018-1854-7","article-title":"DNA methylation-based reclassification of olfactory neuroblastoma","volume":"136","author":"Capper","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2021.11.103_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1349-7006.2011.02175.x","article-title":"Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients","volume":"103","author":"Mukasa","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1016\/j.wneu.2021.11.103_bib5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41416-020-0814-x","article-title":"IDH mutation in glioma: molecular mechanisms and potential therapeutic targets","volume":"122","author":"Han","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.wneu.2021.11.103_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/1176935120915839","article-title":"Computational analysis of IDH1, IDH2, and TP53 mutations in low-grade gliomas including oligodendrogliomas and astrocytomas","volume":"19","author":"Bendahou","year":"2020","journal-title":"Cancer Inform"},{"key":"10.1016\/j.wneu.2021.11.103_bib7","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-12-1773","article-title":"IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives","volume":"18","author":"Yang","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2021.11.103_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10014-019-00348-9","article-title":"Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis","volume":"36","author":"Kuwahara","year":"2019","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.wneu.2021.11.103_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-019-05459-7","article-title":"The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer","volume":"179","author":"Aljohani","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.wneu.2021.11.103_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12105-017-0791-4","article-title":"Update from the 4th edition of the World Health Organization classification of head and neck tumours: tumors of the nasal cavity, paranasal sinuses and skull base","volume":"11","author":"Stelow","year":"2017","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.wneu.2021.11.103_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.anndiagpath.2015.06.008","article-title":"Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?","volume":"19","author":"Singh","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.wneu.2021.11.103_bib12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/blood-2010-03-272146","article-title":"Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia","volume":"116","author":"Thol","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2021.11.103_bib13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/alr.22373","article-title":"Hyams grading as a predictor of metastasis and overall survival in esthesioneuroblastoma: a meta-analysis","volume":"9","author":"Goshtasbi","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.wneu.2021.11.103_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10014-016-0260-x","article-title":"Immunohistochemistry on IDH 1\/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas","volume":"33","author":"Takano","year":"2016","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.wneu.2021.11.103_bib15","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3390\/molecules24050968","article-title":"Consequences of IDH1\/2 mutations in gliomas and an assessment of inhibitors targeting mutated IDH proteins","volume":"24","author":"Kaminska","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.wneu.2021.11.103_bib16","doi-asserted-by":"crossref","first-page":"13398","DOI":"10.1096\/fj.201901366R","article-title":"IDH2 reprograms mitochondrial dynamics in cancer through a HIF-1alpha-regulated pseudohypoxic state","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.wneu.2021.11.103_bib17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/1878-0261.12182","article-title":"IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer","volume":"12","author":"Li","year":"2018","journal-title":"Mol Oncol"},{"key":"10.1016\/j.wneu.2021.11.103_bib18","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/cr.2012.51","article-title":"The mechanisms of IDH mutations in tumorigenesis","volume":"22","author":"Ye","year":"2012","journal-title":"Cell Res"},{"key":"10.1016\/j.wneu.2021.11.103_bib19","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fonc.2020.01514","article-title":"Frequency and prognostic value of IDH mutations in Korean patients with cholangiocarcinoma","volume":"10","author":"Kim","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2021.11.103_bib20","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/modpathol.2016.239","article-title":"Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma","volume":"30","author":"Jo","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.wneu.2021.11.103_bib21","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/PAS.0000000000001064","article-title":"Immunohistochemical detection and molecular characterization of IDH-mutant sinonasal undifferentiated carcinomas","volume":"42","author":"Jeffrey","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.wneu.2021.11.103_bib22","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41379-019-0442-2","article-title":"Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity","volume":"33","author":"Pareja","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.wneu.2021.11.103_bib23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/PAS.0000000000001420","article-title":"IDH2 mutation analysis in undifferentiated and poorly differentiated sinonasal carcinomas for diagnosis and clinical management","volume":"44","author":"Riobello","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.wneu.2021.11.103_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.oraloncology.2017.09.010","article-title":"The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: refinements in diagnostic criteria and impact of multimodal treatments on survival","volume":"74","author":"Turri-Zanoni","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.wneu.2021.11.103_bib25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/his.13954","article-title":"Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma","volume":"75","author":"Classe","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.wneu.2021.11.103_bib26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/0194599820915487","article-title":"Comparing Kadish and modified Dulguerov staging systems for olfactory neuroblastoma: an individual participant data meta-analysis","volume":"163","author":"Arnold","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.wneu.2021.11.103_bib27","doi-asserted-by":"crossref","first-page":"104618","DOI":"10.1016\/j.oraloncology.2020.104618","article-title":"Prognostic factors and outcomes of multimodality treatment in olfactory neuroblastoma","volume":"103","author":"Song","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.wneu.2021.11.103_bib28","doi-asserted-by":"crossref","first-page":"52584","DOI":"10.18632\/oncotarget.9683","article-title":"Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment","volume":"7","author":"Czapiewski","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.wneu.2021.11.103_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11912-014-0423-z","article-title":"Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system","volume":"17","author":"Saade","year":"2015","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.wneu.2021.11.103_bib30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/bpa.12801","article-title":"IDH mutant lower grade (WHO grades II\/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations","volume":"30","author":"Yang","year":"2020","journal-title":"Brain Pathol"},{"key":"10.1016\/j.wneu.2021.11.103_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40478-019-0745-z","article-title":"Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients","volume":"7","author":"Radke","year":"2019","journal-title":"Acta Neuropathol Commun"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875021018015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875021018015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:04:29Z","timestamp":1761815069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875021018015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":31,"alternative-id":["S1878875021018015"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2021.11.103","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic Features and Prognosis of Olfactory Neuroblastoma with Isocitrate Dehydrogenase 2 Mutations","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2021.11.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}